Review Sistem Gerak

download Review Sistem Gerak

of 63

Transcript of Review Sistem Gerak

  • 8/8/2019 Review Sistem Gerak

    1/63

    REVIEW SISTEMREVIEW SISTEMGERAKGERAK

    CompartmentCompartmentSyndromeSyndrome

    zainuri

  • 8/8/2019 Review Sistem Gerak

    2/63

    Review

    Definisi Pening tekanan di dalam ruang kompartemenfascial

    Pathophysiology

    y Intracellular swelling/Hematomay Pressure rises and capillary perfusion drops

    y Tissues vary in susceptibility to damage

    Nerve < 4 hours

    Muscle < 8 hours

    y After 8 hours irreversible damagey Experimentally

    Within 10mmHg of diastolic pressure

    Injured tissue 20 mmHg

  • 8/8/2019 Review Sistem Gerak

    3/63

    Review

    Etiologyy Temporary vascular occlusion

    Trauma, thrombus

    Clinical Presentationy History of injury / energy absorbedy Swelling, Pain

    y Passive stretch

    y Pallor, paresthesia, pulselessness, paralysis

    Investigationy Compartmental pressure measurements

    y Dont delay getting measurements if diagnosis is obvious (20mmHG less than diastolic)

  • 8/8/2019 Review Sistem Gerak

    4/63

    Review

    Treatmenty Remove dressings

    y Do not excessively elevate the foot

    Level of the heart

    y Analgesia

    y Have low threshold to proceed surgically

    y Emergency fascial release

    y 3 incisions

    1 medial 2 Dorsal

    yDivide fascia

    y Delayed closure

    +/- skin grafting

    y Prophylactic releases

  • 8/8/2019 Review Sistem Gerak

    5/63

    komplikasi

    Early

    y Myonecrosis

    y Renal concerns

    Late

    y Deformities from contracture of necrotic

    muscle

    y Nerve Injury Ulcerations

  • 8/8/2019 Review Sistem Gerak

    6/63

    osteomyelitisosteomyelitis

    zainuri

  • 8/8/2019 Review Sistem Gerak

    7/63

    Review

    Definisi INFLAMMATORY PROCESS IN BONE & BONEMARROW ACUTE & CHRONIC

    Pathophysiology Hematogenous Osteomyelitis

    Contiguous-Focus Osteomyelitis

    Peripheral Vascular Disease-associated

    Bacteria escape host defenses by: Adhering tightly to damage bonePersisting in osteoblastsProtective polysaccharide-rich biofilm

  • 8/8/2019 Review Sistem Gerak

    8/63

    PATHOPHYSIOLOGYPATHOPHYSIOLOGYMicroorganisms enter bone (Phagocytosis).

    Phagocyte contains the infection

    Release enzymes

    Lyse bone

  • 8/8/2019 Review Sistem Gerak

    9/63

    PATHOPHYSIOLOGYPATHOPHYSIOLOGY

    Pus spreads into vascular channels

    Raising intraosseous pressure

    Impairing blood flow

    Chronic ischemic necrosis

    Separation of large devascularized fragment

    New bone formation

    (involucrum)

    (Sequestra)(Sequestra)

  • 8/8/2019 Review Sistem Gerak

    10/63

    PATHOLOGYPATHOLOGY

    Acute Infiltration of PMNsCongested or thrombosed vessels

    Chronic Necrotic bone Absence of living osteocyteMononuclear cells predominateGranulation & fibrous tissue

  • 8/8/2019 Review Sistem Gerak

    11/63

    HEMATOGENOUS OSTEPMYELITISHEMATOGENOUS OSTEPMYELITIS

    Rapidly growing boneRapidly growing boneChildren:Children:

    Long bone, Femur, Tibia,Long bone, Femur, Tibia, HumerusHumerus

    Older patients: Vertebral boneOlder patients: Vertebral bone

    Neonate & infant < 1 year oldNeonate & infant < 1 year old

    Septic arthritis is common.Septic arthritis is common.Growth deformities is common.Growth deformities is common.Soft tissue involvement is common.Soft tissue involvement is common.

  • 8/8/2019 Review Sistem Gerak

    12/63

    HEMATOGENOUS OSTEOMYELITISHEMATOGENOUS OSTEOMYELITIS

    Clinical manifestationClinical manifestationClassic presentation: Sudden onsetClassic presentation: Sudden onsetUsually presentation: Slow, insidiousUsually presentation: Slow, insidious

    High fever, Night sweatsHigh fever, Night sweatsFatigue, Anorexia, Weight lossFatigue, Anorexia, Weight loss

    Restriction of movementRestriction of movementLocal edema, Erythema, &Local edema, Erythema, & TenderrnessTenderrness

  • 8/8/2019 Review Sistem Gerak

    13/63

    HEMATOGENOUS OSTEOMYELITISHEMATOGENOUS OSTEOMYELITIS

    DifferentialsDifferentialsCellulitisCellulitis

    Gas gangreneGas gangreneNeoplasmNeoplasm Aseptic bone infection Aseptic bone infection

  • 8/8/2019 Review Sistem Gerak

    14/63

    Clenched fistClenched fist

    osteomyelitisosteomyelitis

  • 8/8/2019 Review Sistem Gerak

    15/63

    HEMATOGENOUS OSTEOMYELITISHEMATOGENOUS OSTEOMYELITIS

    Diagnosis & workDiagnosis & work--upupLab study:Lab study:WBCWBC May be elevated, Usually normalMay be elevated, Usually normal

    CC--Reactive Protein (CRP)Reactive Protein (CRP)

    Erythrocyte Sedimentation RateErythrocyte Sedimentation Rate(Usually is elevated at presentation(Usually is elevated at presentationFalls with successful therapy)Falls with successful therapy)

    Blood cultureBlood culture( Acute osteomyelitis + ve > 50% )( Acute osteomyelitis + ve > 50% )

    {{

  • 8/8/2019 Review Sistem Gerak

    16/63

    HEMATOGENOUS OSTEOMYELITISHEMATOGENOUS OSTEOMYELITIS

    Diagnosis & workDiagnosis & work--upupImagingImaging

    Radiology:Radiology:NormalNormalSoft tissue swellingSoft tissue swellingPeriosteal elevationPeriosteal elevationLytic changeLytic changeSclerotic changewSclerotic changew

  • 8/8/2019 Review Sistem Gerak

    17/63

    HEMATOGENOUS OSTEOMYELITISHEMATOGENOUS OSTEOMYELITIS

    Diagnosis & workDiagnosis & work--upupUltrasonographyUltrasonography

    Simple & inexpensiveSimple & inexpensive

    Demonstration anomaly 1Demonstration anomaly 1 2 days after onset2 days after onset

    Soft tissue abscess, Fluid collection, &Soft tissue abscess, Fluid collection, &Periosteal elevationPeriosteal elevation

    It allows for aspirationIt allows for aspiration

    It doesnt allow for evaluation of bone cortex.It doesnt allow for evaluation of bone cortex.

  • 8/8/2019 Review Sistem Gerak

    18/63

    TREATMENTTREATMENT

    Initial treatmentInitial treatment shoudshoud be aggressive.be aggressive.Inadequate therapyInadequate therapy Chronic diseaseChronic disease Antibiotic use: Antibiotic use:

    ParenteralParenteralHigh dosesHigh doses

    Good penetration in boneGood penetration in boneFull courseFull courseEmpiric therapyEmpiric therapy

    SurgerySurgeryDiagnosticDiagnosticHip joint involvementHip joint involvementNeurologic complicationNeurologic complicationPoor or no response to IV therapyPoor or no response to IV therapy

    SequestrationSequestration

  • 8/8/2019 Review Sistem Gerak

    19/63

    ContiguousContiguous--focus Osteomyelitisfocus Osteomyelitis

    Clinical setting:Clinical setting:Postoperative infectionPostoperative infectionContamination of boneContamination of boneContiguous soft tissue infectionContiguous soft tissue infection

    Puncture woundsPuncture wounds

    Microbiologic featuresMicrobiologic features

    StaphylococciStaphylococci AureusAureus,, EpidermidisEpidermidis

    GramGram--negative bacterianegative bacteria Anaerobic infection Anaerobic infectionUnusual organismsUnusual organisms Clostridia,Clostridia, NocardiaNocardia

  • 8/8/2019 Review Sistem Gerak

    20/63

    ContiguousContiguous--focus Osteomyelitisfocus Osteomyelitis

    DiagnosisDiagnosisLeukocyte countLeukocyte countBlood culture (infrequently positive)Blood culture (infrequently positive)ESR & CRPESR & CRP

    Radiologic evaluationRadiologic evaluationTechnetium bone scanTechnetium bone scanOpen bone biopsyOpen bone biopsyCulture of wound & draining sinuses??Culture of wound & draining sinuses??

    TreatmentTreatmentSurgery is essential.Surgery is essential.

    AntibioticsAntibiotics SpecificSpecific

    DurationDuration

  • 8/8/2019 Review Sistem Gerak

    21/63

    ArthritisArthritis

    zainuri

  • 8/8/2019 Review Sistem Gerak

    22/63

    review

    l Types ofarthritis

    l Symptoms ofarthritis

    l Signs ofarthritis

    l Treatment ofarthritis

  • 8/8/2019 Review Sistem Gerak

    23/63

    Types of Arthritis

    l Rheumatoid arthritis (RA)

    l Osteoarthritis (OA)

    l Sero-negative arthritis

    l Ankylosing spondylitis

    l

    Reiters diseasel Crystal arthropathies

  • 8/8/2019 Review Sistem Gerak

    24/63

    Rheumatoid Arthritis

    Pathology

    l Synovitis

    chronic infl, synovial hypertrophy,effusion

    l Destruction

    proteolytic enzymes, pannus

    l Deformity

    articular destruction, capsular stretching,tendon rupture

  • 8/8/2019 Review Sistem Gerak

    25/63

    Rheumatoid Arthritis

    extra-articular

    l nodules

    l tendon sheathl vasculitis

    l myopathy and neuropathy

    l

    reticulo-endothelial systeml visceral - lungs, heart, kidneys, brain, GI

  • 8/8/2019 Review Sistem Gerak

    26/63

    Rheumatoid Arthritis

    early symptoms

    myopathy, tiredness, weight loss, malaise proximal finger joints wrists, feet, knees, shoulders

    start up pain tendon crepitus

    late symptoms

    joint destruction pain

    deformity

    instability

  • 8/8/2019 Review Sistem Gerak

    27/63

  • 8/8/2019 Review Sistem Gerak

    28/63

  • 8/8/2019 Review Sistem Gerak

    29/63

  • 8/8/2019 Review Sistem Gerak

    30/63

  • 8/8/2019 Review Sistem Gerak

    31/63

    Rheumatoid Arthritis

    advanced joint changes

  • 8/8/2019 Review Sistem Gerak

    32/63

    Rheumatoid Arthritis

    X-ray findings

    joint space narrowing

    peri-articular osteopenia

    erosions

  • 8/8/2019 Review Sistem Gerak

    33/63

    Rheumatoid Arthritis

    treatment stop synovitis prevent deformity

    reconstruct

    Rehabilitate

    Prognosis

    10% improve

    60% intermittent, slowly worsening

    20% severe joint erosion, multiple surgery

    10% completely disabled

  • 8/8/2019 Review Sistem Gerak

    34/63

    Osteoarthritis

    A chronic joint disorder in which there is

    progressive softening and disintegration

    of articular cartilage accompanied by

    new growth of cartilage and bone at the

    joint margins (osteophytes) and capsular

    fibrosis

  • 8/8/2019 Review Sistem Gerak

    35/63

    Osteoarthritis

    classification

    Primary or idiopathic

    Secondary - infection

    - dysplasia

    - Perthes

    - SUFE

    - trauma

    - AVN

  • 8/8/2019 Review Sistem Gerak

    36/63

    Osteoarthritis

    aetiology

    Genetic

    metabolic hormonal

    mechanical

    ageing

  • 8/8/2019 Review Sistem Gerak

    37/63

    Osteoarthritis

    mechanism 1

    Disparity between:-

    stress applied to articular cartilage

    and

    strength of articular cartilage

  • 8/8/2019 Review Sistem Gerak

    38/63

    Osteoarthritis

    mechanism 2

    Increased stress (F/A)

    increased load eg BW or activity decreased area eg varus knee or

    dysplastic hip

  • 8/8/2019 Review Sistem Gerak

    39/63

    Osteoarthritis

    mechanism 3

    Weak cartilage

    age

    stiff eg ochronosis

    soft eg inflammation

    abnormal bony support eg AVN

  • 8/8/2019 Review Sistem Gerak

    40/63

    Osteoarthritis

    X-ray changes

    joint space narrowing

    subchondral sclerosis osteophytes

    cysts

  • 8/8/2019 Review Sistem Gerak

    41/63

    Osteoarthritis

    X-ray changes

  • 8/8/2019 Review Sistem Gerak

    42/63

    Arthritis

    symptoms

    pain

    swelling stiffness

    deformity

    instability

    loss of function

  • 8/8/2019 Review Sistem Gerak

    43/63

    Arthritis

    non-surgical treatment

    analgesia

    disease modifying drugs (RA) altered activity

    walking aids

    physiotherapy

  • 8/8/2019 Review Sistem Gerak

    44/63

    Arthritis

    surgical treatment

    arthroscopy osteotomy

    arthrodesis

    excision arthroplasty

    replacement arthroplasty

  • 8/8/2019 Review Sistem Gerak

    45/63

    Arthritis

    knee arthroplasty

  • 8/8/2019 Review Sistem Gerak

    46/63

    Joint Replacement

    indications

    Disabling pain

    Functional limitations

    History

    pain

    function medical

    expectations

  • 8/8/2019 Review Sistem Gerak

    47/63

    Joint Replacement

    investigation

    X-ray - alignment

    - deformity

    - previous fractures and implants- AVN

    - osteophytes

    - bone loss CT, MRI, bone scan - rarely

  • 8/8/2019 Review Sistem Gerak

    48/63

    Ankylosing Spondylitis

    0.2% of population

    mainly affects spine and SI joints male > female

    HLA B27 in 90%

    synovitis

    enthesopathy

  • 8/8/2019 Review Sistem Gerak

    49/63

    Ankylosing Spondylitis

    hips and knees

    flexion deformities

    arthritis with large osteophytes ankylosis

  • 8/8/2019 Review Sistem Gerak

    50/63

    Ankylosing Spondylitis

    X-ray changes

    joint space narrowing

    large osteophytes heterotopic bone

    ankylosis

  • 8/8/2019 Review Sistem Gerak

    51/63

    Tumor MusculoskeletalTumor Musculoskeletal

    zainuri

  • 8/8/2019 Review Sistem Gerak

    52/63

    Introduction

    PrimaryMusculoskeletal tumorsarise from tissue ofmesenchymal origin (ie.bone, muscle,

    connective tissue,adipose.)

    These primary tumorsmay spread to othersites, usually other

    bones or lung. Secondary bone tumors

    arise from a host ofother tissues and in theappropriate age

    category must be

  • 8/8/2019 Review Sistem Gerak

    53/63

    Introduction

    The work-up of any tumor must be

    thought of in terms ofLocal disease

    and Systemic disease.

    By doing so you will have a sensible

    approach to determining the ultimate

    pathologic diagnosis and the extent of

    the disease in the body.

  • 8/8/2019 Review Sistem Gerak

    54/63

    Local Investigations

    X-ray.the mosthelpful in focusing ourdifferential and furtherinvestigations.

    Cat scan.. Bonearchitecture,neocorticalization,?fracture.

    MRI.marrow extent,soft tissue extent,neurovascularinvolvement, skip

    lesions.

  • 8/8/2019 Review Sistem Gerak

    55/63

    Radiographic Features of the

    Various Tumors Benign: well circumscribed, narrow transition,

    no reaction, sclerotic border, does onething.

    Benign Aggressive: neocorticalization,expansion, thinning of cortex, usually lytic,+/-reaction, +/- narrow zone of transition.

    Malignant: ++++reaction, large, permeative,moth eaten, does more than one thing.

    Conditions/Mets: more than one bone,symmetry.

  • 8/8/2019 Review Sistem Gerak

    56/63

    Invasive Investigation

    Biopsy..the goal is to obtain a piece of

    tissue adequate to make a pathologic

    diagnosis.

    Should be done after all other

    investigations are complete

    Needle, Tru-cut, incisional.

    CT/US guided.

  • 8/8/2019 Review Sistem Gerak

    57/63

    Primary Bone Tumors

    Osteogenic

    Fibrous

    Chondroid Lipomatous

    Other

    *****These are thebroadcategories******

  • 8/8/2019 Review Sistem Gerak

    58/63

    Osteogenic

    Benign: Osteoma,Osteoid Osteoma,Bone Islands

    Benign Aggressive:Osteoblastoma

    Malignant:OsteogenicSarcoma

  • 8/8/2019 Review Sistem Gerak

    59/63

    Fibrous Tumours

    Benign: Fibrous Cortical

    Defect, Non-Ossifying

    Fibroma, Fibroma of

    Bone. Benign Aggressive:

    Fibromatosis(desmoid),

    Ossifying Fibroma of

    bone, Fibrous Dysplasia.

    Malignant: Malignant

    Fibrous Histiocytoma of

    bone, Fibrosarcoma.

  • 8/8/2019 Review Sistem Gerak

    60/63

    Chondroid

    Benign:Enchondroma, Peri-

    osteal Chondroma,

    Osteochondroma.

    Benign Aggressive:

    Chondromyxoid

    Fibroma,

    Chondroblastoma.

    Malignant:

    Chondrosarcoma.

  • 8/8/2019 Review Sistem Gerak

    61/63

    Other Bone Tumors

    Benign: Bone Cyst,Ganglion,Hemangioma.

    Benign Aggressive:

    Giant Cell Tumor,Aneurysmal BoneCyst, EOG.

    Malignant:

    Adamantinoma,Chordoma, Ewings.

  • 8/8/2019 Review Sistem Gerak

    62/63

    Sites of Tumors

    Diaphyseal: Ewings, Osteoid Osteoma,

    Mets, Adamantinoma, Fibrous

    Dysplasia

    Epiphyseal: Chondroblastoma, Clear

    Cell Chondrosarcoma, GCT, Ganglion of

    Bone.

    Metaphyseal: Everything!!!!!!

  • 8/8/2019 Review Sistem Gerak

    63/63

    Age of Tumors

    20>..Osteogenic Sarcoma, Ewings.

    40GCT, Chondrosarcoma, MFH,

    Lymphoma, Mets.

    60Mets, Myeloma,

    Chondrosarcoma, late Osteogenic,MFH, Fibrosarcoma.